Eisai and Nuvation Bio Enter into Exclusive Licensing Agreement for Taletrectinib in Europe and Additional Countries Outside the U.S., China and Japan

TOKYO and NEW YORK, NY., Jan 13, 2026 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”), a human-centered global leading research-based pharmaceutical company working in the neurology and oncology therapeutic areas, and Nuvation Bio Inc. (NYSE: NUVB, Corporate Headquarters: New York, NY, CEO:…

Fujitsu develops digital learning platform for JAL to support self-directed learning and training management

KAWASAKI, Japan, Jan 9, 2026 - (JCN Newswire via SeaPRwire.com) - Fujitsu Limited today announced that it has jointly developed a new digital learning platform with Japan Airlines Co., Ltd. (JAL) to support educational training improvements at JAL's airport sites. The platform, which leverages Fujitsu's digital learning solution Advanced Teaming…

TOYOTA GAZOO Racing Reverting to “GAZOO Racing” to Pass on and Evolve the Making of Ever-better Cars and the Fostering of Talent

TOKYO, Jan 7, 2026 - (JCN Newswire via SeaPRwire.com) - TOYOTA GAZOO Racing (TGR) today announced that, to return to its founding principles, it is reverting to the name "GAZOO Racing" to strengthen its motorsports-bred making of ever-better cars and the fostering of talent.TOYOTA GAZOO Racing is reverting its name to…

TANAKA PRECIOUS METAL GROUP and TANAKA MIRAI Lab. Release “The TANAKA 2025” a Perfume that Expresses the Fragrance of Gold (Au)

TOKYO, Jan 7, 2026 - (JCN Newswire via SeaPRwire.com) - TANAKA MIRAI Lab., an in-house innovation organization of TANAKA PRECIOUS METAL GROUP Co., Ltd. (head office: Chuo-ku, Tokyo; Group CEO: Koichiro Tanaka), launched the Precious Fragrance Project in fiscal year 2025 as part of its initiatives in the new "Precious Things"…

Biologics License Application for Subcutaneous Formulation of “LEQEMBI(R)” (lecanemab) for the Treatment of Early Alzheimer’s Disease Accepted in China

TOKYO and CAMBRIDGE, Mass., Jan 6, 2026 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today that the Biologics License Application (BLA) for the subcutaneous formulation (subcutaneous autoinjector:…

Alpha Growth plc: Alpha Longevity Management Ltd Expands Global Platform with Launch of Alpha Alternative Global Fund and Strengthening of Executive Leadership Team

LONDON, Jan 5, 2026 - (JCN Newswire via SeaPRwire.com) - Alpha Growth plc, (www.algwplc.com) a leading global financial services specialist in the multi-billion dollar market of longevity assets and insurance linked asset and wealth management is pleased to announce that one of its group companies, Alpha Longevity Management Ltd, an asset…